A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
about
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase II study of a dose-den ...... en with primary breast cancer.
@ast
A phase II study of a dose-den ...... en with primary breast cancer.
@en
type
label
A phase II study of a dose-den ...... en with primary breast cancer.
@ast
A phase II study of a dose-den ...... en with primary breast cancer.
@en
prefLabel
A phase II study of a dose-den ...... en with primary breast cancer.
@ast
A phase II study of a dose-den ...... en with primary breast cancer.
@en
P2093
P1433
P1476
A phase II study of a dose-den ...... men with primary breast cancer
@en
P2093
Alessio Schirone
Andrea Rocca
Barbara Kopf
Cecilia Menna
Dino Amadori
Elisabetta Pietri
Francesca Fabbri
Ugo De Giorgi
P304
P356
10.1634/THEONCOLOGIST.2014-0326
P577
2015-01-30T00:00:00Z